Skip to main content
. 2017 Apr 7;8:179. doi: 10.3389/fphar.2017.00179

Table 1.

Patients' clinical and pathological characteristics.

Patients characteristics CHR status No. patients (%)
CHR positive, N = 16 CHR negative, N = 31
Median age at diagnosis of LLG months (range) 34 (12–72) 53.5 (12–156)
NF1 2 (12.5) 5 (16.1)
Boys/girls 8/8 14/17
Diencephalic location 13 (81.2) 24 (77.4)
Monthly carboplatin administration 10 (62.5) 8 (25.8)
Weekly carboplatin administration 6 (37.5) 23 (74.2)